Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 29, 2017 | $166B |
| FY2017, ended Jan 28, 2018 | $240B |
| FY2018, ended Feb 3, 2019 | $204B |
| FY2019, ended Feb 2, 2020 | $245B |
| FY2020, ended Jan 31, 2021 | $292B |
| FY2021, ended Jan 30, 2022 | $379B |
| FY2022, ended Jan 29, 2023 | $321B |
| FY2023, ended Jan 28, 2024 | $352B |
| FY2024, ended Feb 2, 2025 | $410B |
| FY2025, ended Feb 1, 2026 | $373B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $331B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 29, 2017 | $94.6B |
| FY2017, ended Jan 28, 2018 | $101B |
| FY2018, ended Feb 3, 2019 | $108B |
| FY2019, ended Feb 2, 2020 | $110B |
| FY2020, ended Jan 31, 2021 | $132B |
| FY2021, ended Jan 30, 2022 | $151B |
| FY2022, ended Jan 29, 2023 | $157B |
| FY2023, ended Jan 28, 2024 | $153B |
| FY2024, ended Feb 2, 2025 | $160B |
| FY2025, ended Feb 1, 2026 | $165B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $169B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 29, 2017 | $7.96B | $8.16B |
| FY2017, ended Jan 28, 2018 | $8.63B | $10.1B |
| FY2018, ended Feb 3, 2019 | $11.1B | $10.7B |
| FY2019, ended Feb 2, 2020 | $11.2B | $11.0B |
| FY2020, ended Jan 31, 2021 | $12.9B | $16.4B |
| FY2021, ended Jan 30, 2022 | $16.4B | $14.0B |
| FY2022, ended Jan 29, 2023 | $17.1B | $11.5B |
| FY2023, ended Jan 28, 2024 | $15.1B | $17.9B |
| FY2024, ended Feb 2, 2025 | $14.8B | $16.3B |
| FY2025, ended Feb 1, 2026 | $14.2B | $12.6B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $14.2B | $15.1B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 29, 2017 | $2.54B |
| FY2017, ended Jan 28, 2018 | $3.60B |
| FY2018, ended Feb 3, 2019 | $1.78B |
| FY2019, ended Feb 2, 2020 | $2.13B |
| FY2020, ended Jan 31, 2021 | $7.89B |
| FY2021, ended Jan 30, 2022 | $2.34B |
| FY2022, ended Jan 29, 2023 | $2.76B |
| FY2023, ended Jan 28, 2024 | $3.76B |
| FY2024, ended Feb 2, 2025 | $1.66B |
| FY2025, ended Feb 1, 2026 | $1.39B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $2.08B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 29, 2017 | $23.6B |
| FY2017, ended Jan 28, 2018 | $27.0B |
| FY2018, ended Feb 3, 2019 | $29.2B |
| FY2019, ended Feb 2, 2020 | $30.5B |
| FY2020, ended Jan 31, 2021 | $34.8B |
| FY2021, ended Jan 30, 2022 | $37.4B |
| FY2022, ended Jan 29, 2023 | $41.1B |
| FY2023, ended Jan 28, 2024 | $42.1B |
| FY2024, ended Feb 2, 2025 | $51.7B |
| FY2025, ended Feb 1, 2026 | $53.9B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $52.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 17.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 29, 2017 | 1.20B |
| FY2017, ended Jan 28, 2018 | 1.16B |
| FY2018, ended Feb 3, 2019 | 1.10B |
| FY2019, ended Feb 2, 2020 | 1.07B |
| FY2020, ended Jan 31, 2021 | 1.08B |
| FY2021, ended Jan 30, 2022 | 1.03B |
| FY2022, ended Jan 29, 2023 | 1.01B |
| FY2023, ended Jan 28, 2024 | 991M |
| FY2024, ended Feb 2, 2025 | 994M |
| FY2025, ended Feb 1, 2026 | 996M |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | 998M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Jan 29, 2017 | $6.88B | $267M | $218M |
| FY2017, ended Jan 28, 2018 | $8.00B | $273M | $255M |
| FY2018, ended Feb 3, 2019 | $9.96B | $282M | $236M |
| FY2019, ended Feb 2, 2020 | $6.96B | $251M | $280M |
| FY2020, ended Jan 31, 2021 | $791M | $310M | $326M |
| FY2021, ended Jan 30, 2022 | $14.8B | $399M | $337M |
| FY2022, ended Jan 29, 2023 | $6.70B | $366M | $264M |
| FY2023, ended Jan 28, 2024 | $7.95B | $380M | $323M |
| FY2024, ended Feb 2, 2025 | $649M | $442M | $395M |
| FY2025, ended Feb 1, 2026 | $0 | $522M | $314M |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | — | $560M | $343M |
Valuation
At current price- Market Cap
- $318B
- P/E
- 22.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.9×
- Price / Book
- 19.1×
- EV / EBITDA
- 14.9×
Growth
Trailing 12 months- Revenue (TTM)
- $169B
- Revenue Growth YoY
- 2.5%
- Revenue CAGR 3Y
- 1.5%
- Revenue CAGR 5Y
- 4.5%
- EPS Growth YoY
- −2.9%
- Net Income Growth YoY
- −2.7%
Profitability
Trailing 12 months- Gross Margin
- 33.2%
- Operating Margin
- 12.4%
- Net Margin
- 8.4%
- FCF Margin
- 8.9%
- Return on Equity
- 104%
Earnings
Trailing 12 months- Net Income
- $14.2B
- EPS (diluted)
- $14.29
- EBITDA
- $24.7B
- Operating Income
- $21.0B
Balance Sheet
As of Aug 2, 2026- Cash and cash equivalents
- $2.08B
- Total Debt
- $52.9B
- Net Debt
- $50.8B
- Total Assets
- $109B
- Total Liabilities
- $92.8B
- Shareholders' Equity
- $16.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $18.8B
- Capital Expenditure
- $3.68B
- Free Cash Flow
- $15.1B
Dividends and risk
Last 12 months- Dividend Yield
- 2.9%
- Dividend / Share
- $9.29
- Beta (5Y)
- 0.99
Every ratio is calculated from the company’s reported figures.